Home » Newsletters » BioWorld Science

BioWorld Science

March 11, 2020

View Archived Issues

'Gut bug' has intratumoral effects

Decoy exosomes fight bacterial toxin

AbbVie begins first-in-human study of ABBV-184 in previously treated AML and NSCLC

NCI selects Curadigm's Nanoprimer technology for characterization

Mesoblast to evaluate remestemcel-L for treatment of COVID-19 lung disease

Brilacidin to be tested against COVID-19

FDA clears IND applications for phase I study of CAD-9303 in schizophrenia

Nuclear NR4A3 expression as novel diagnostic biomarker of ACC-SG

SATB2 as novel biomarker of neuroendocrine differentiation in gynecological tumors

Broadly neutralizing antibody plus latency reversing treatment evaluated in HIV trial

Novel 18F-labeled tryptophan analogue as a PET imaging probe for Shh medulloblastoma

GEMoaB initiates first-in-human study of UniCAR-T-CD123 in acute leukemias

Chinese researchers patent JAK inhibitors

Rudong Ringene Pharmaceuticals divulges FGFR inhibitors

AZD-2373 begins first-in-human trial in healthy male subjects of African ancestry

KeyBioscience discloses new compounds for diabetes

Beijing Yuezhikangtai Biomedicines presents new tyrosine kinase inhibitors

Beijing Scitech-Mq Pharmaceuticals identifies VEGFR-2 and CSF-1R inhibitors

Researchers debut open-source platform for in silico small molecule screening

Neoantigen-rich murine melanoma cell model devised to study checkpoint inhibitor responses

First phase I study of cannabinol cream INM-755 completes enrollment

Gilead presents 96-week data from DISCOVER trial of Descovy for PrEP

Tiziana accelerates development of TZLS-501 for COVID-19

Novo Nordisk initiates phase I study of NNC0472-0147 for type 2 diabetes

Nucana reports preliminary data from phase II study of Acelarin in ovarian cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...